Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial

NCT02648464 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction
Acute Coronary Syndrome
Inflammation
Hydroxychloroquine
Antirheumatic Agents
Cardiovascular Diseases

Interventions

DRUG: Hydroxychloroquine
DRUG: Placebo

Sponsor

Helsinki University Central Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]